about
Consensus on the role of human cytomegalovirus in glioblastomaThe roles of viruses in brain tumor initiation and oncomodulationCancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsMedulloblastoma-biology and microenvironment: a reviewCytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsChronic viral infection and primary central nervous system malignancy.Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γReptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancerEffect of a qigong intervention program on telomerase activity and psychological stress in abused Chinese women: a randomized, wait-list controlled trial.The oncogenic potential of human cytomegalovirus and breast cancer.Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study.Human cytomegalovirus infection is sensitive to the host cell DNA methylation state and alters global DNA methylation capacity.Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or gradeHigh prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes.TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinomaCytomegalovirus and Epstein-Barr virus in breast cancerHuman immunoglobulin G levels of viruses and associated glioma riskUbiquitin-independent proteasomal degradation during oncogenic viral infections.Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetGeneration of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.Telomeres and viruses: common themes of genome maintenance.Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancerTelomerase as a useful target in cancer fighting-the breast cancer case.Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent mannerCidofovir: a novel antitumor agent for glioblastoma.Is HCMV a tumor promoter?Human telomerase expression regulation.The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses.Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.Is human cytomegalovirus a target in cancer therapy?Treatment of cytomegalovirus infections beyond acute disease to improve human health.Cytomegalovirus and glioma: putting the cart before the horse.Cytomegalovirus and glioblastoma; controversies and opportunities.Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samplesCytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?
P2860
Q24632103-FB0B4B20-85C3-4B8B-B7A7-5F6542E367A1Q24632829-4696B8E5-9297-4BE5-9C19-B713ED5DD156Q26738705-53C803A6-172C-4042-8A58-B7C71467FC12Q26995823-6361F207-8709-4FEE-9F30-EE1C6D7A436EQ26996612-5A15B7C8-66E1-4C8E-9A27-7FE57F84877AQ30480064-5E3436E4-1772-4102-9A0E-2575B59F485DQ33778830-F01EB2D7-472B-4476-94D5-7282D7C369A3Q33886711-C38F5823-6D84-4BB4-AB9D-1EF42721D356Q33921644-16741754-BCAD-41B6-B0B2-EF0D860E2D7AQ34067550-6ADE9751-20C4-4F17-9525-ADA0B57EE806Q34081724-9CC65FE9-769D-4CCB-8946-DAD291638E29Q34145201-594952A3-F282-4F07-99C4-AD9505B7ABB1Q34198365-B39788DB-8843-489C-BB16-A7236A7D778CQ34275714-F46FD572-60D4-4948-8E7A-738D4619166EQ34277652-4E28002E-D3C7-4B3F-B98A-A3EF689524ADQ34602649-7484B87A-957A-4CAE-82FE-32C1E8605C52Q34654382-CB634B90-1CCB-4E36-93DD-38544BCFA33FQ35130194-A1C86020-63A9-4E82-8938-690BD1105C06Q35136924-CB791119-0F49-462C-A7B9-31BF373D85D7Q35354212-34542F06-EE6F-4A59-8372-F2D9DD7ADBFEQ35370135-8E07B735-956D-412A-83F9-DC0106793183Q35759682-22CBD687-AD75-49A5-86E3-E4405D21AA2DQ35943427-8BF96D68-B3E3-4547-B289-BDD36484EEC9Q36080884-6CE0FD25-7846-4B33-830D-41EF8F9359D5Q36497017-B45C53FE-ED0B-406B-B22C-879859D19AC3Q36650811-DA79FA6F-1E6E-45C5-8931-133072561825Q36868580-1FC3F34D-C458-47C9-B678-B1EDA0A9D51EQ37046392-AFBE029A-AE53-4EF3-AC69-B32F3BD2305AQ37574749-FB904D6B-412A-4171-830E-23B22A110137Q37805181-59BDD7D8-D913-476B-91FF-13F09979BE8FQ37905799-B9625C28-780D-447A-B216-7AF676B36FCDQ37945177-43339754-9037-4330-9CD6-7F8EAD7E3156Q37949710-95438E36-1F61-499A-8A76-FC0173B09736Q37975925-B6FC1976-4DD0-492C-8B6C-16DB830850EBQ38176940-37767988-75DF-4C60-A1B3-4178DCF17074Q38218302-50728C28-D3F7-4690-9565-A6E853408244Q38355706-5CEC7B47-CE0D-451B-B8F1-A5D78D6651E3Q38407022-89A56690-631F-4B25-803E-66E40896EDADQ38773347-946BA8AF-8AEC-494F-BD65-5BC6E127035BQ39153890-C63AC36F-317F-4416-8126-D711D4A0EA77
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Activation of telomerase by human cytomegalovirus.
@en
Activation of telomerase by human cytomegalovirus.
@nl
type
label
Activation of telomerase by human cytomegalovirus.
@en
Activation of telomerase by human cytomegalovirus.
@nl
prefLabel
Activation of telomerase by human cytomegalovirus.
@en
Activation of telomerase by human cytomegalovirus.
@nl
P2093
P2860
P50
P356
P1476
Activation of telomerase by human cytomegalovirus.
@en
P2093
Fenglan Lou
Jan Sjöberg
Magnus Björkholm
Nina Wolmer-Solberg
Qingjun Zhu
P2860
P304
P356
10.1093/JNCI/DJP031
P407
P577
2009-03-24T00:00:00Z